ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 149 filers reported holding ASCENDIS PHARMA A/S in Q1 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,113,343 | -63.8% | 33,248 | -65.5% | 0.00% | -100.0% |
| Q2 2023 | $8,610,126 | -56.3% | 96,472 | -47.5% | 0.00% | -75.0% |
| Q1 2023 | $19,717,973 | -57.2% | 183,902 | -51.2% | 0.00% | -63.6% |
| Q4 2022 | $46,016,874 | +97.4% | 376,786 | +66.9% | 0.01% | +120.0% |
| Q3 2022 | $23,310,000 | +70.6% | 225,740 | +53.6% | 0.01% | +66.7% |
| Q2 2022 | $13,664,000 | -32.2% | 146,988 | -14.4% | 0.00% | -25.0% |
| Q1 2022 | $20,163,000 | +94.8% | 171,800 | +123.3% | 0.00% | +300.0% |
| Q4 2021 | $10,349,000 | -4.8% | 76,926 | +12.8% | 0.00% | -50.0% |
| Q3 2021 | $10,867,000 | -73.8% | 68,178 | -78.4% | 0.00% | -77.8% |
| Q2 2021 | $41,474,000 | +133.7% | 315,275 | +128.9% | 0.01% | +125.0% |
| Q1 2021 | $17,748,000 | -68.4% | 137,715 | -59.1% | 0.00% | -71.4% |
| Q4 2020 | $56,207,000 | -29.3% | 337,014 | -34.6% | 0.01% | -39.1% |
| Q3 2020 | $79,504,000 | +7.8% | 515,187 | +3.3% | 0.02% | -11.5% |
| Q2 2020 | $73,735,000 | +141.4% | 498,543 | +83.8% | 0.03% | +100.0% |
| Q1 2020 | $30,540,000 | -49.8% | 271,200 | -38.0% | 0.01% | -50.0% |
| Q4 2019 | $60,863,000 | +758.4% | 437,482 | +494.3% | 0.03% | +766.7% |
| Q3 2019 | $7,090,000 | -77.0% | 73,612 | -72.5% | 0.00% | -78.6% |
| Q2 2019 | $30,834,000 | -65.2% | 267,768 | -64.4% | 0.01% | -68.9% |
| Q1 2019 | $88,637,000 | +1106.9% | 753,076 | +542.5% | 0.04% | +1025.0% |
| Q4 2018 | $7,344,000 | +240.3% | 117,209 | +284.9% | 0.00% | – |
| Q3 2018 | $2,158,000 | -13.4% | 30,449 | -18.8% | 0.00% | -100.0% |
| Q2 2018 | $2,493,000 | +570.2% | 37,478 | +264.8% | 0.00% | – |
| Q3 2017 | $372,000 | +1671.4% | 10,273 | +788.7% | 0.00% | – |
| Q4 2015 | $21,000 | -67.7% | 1,156 | -68.6% | 0.00% | – |
| Q3 2015 | $65,000 | -93.8% | 3,687 | -93.9% | 0.00% | -100.0% |
| Q1 2015 | $1,046,000 | – | 60,316 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |